Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

LAA Closure for Atrial Fibrillation using Occlusion Device

Congenital and Structural Interventions

H. Sievert

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: Fact, Fict…

Houston Methodist DeBakey Heart and Vascular Center

R. Passman

START: Stroke Prevention Through AFib Recognition and Treatment

The France Foundation

K. Newlin, L. Vanbrocklin

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Management of Device Detected AF

Taya Glotzer

How Much Atrial Fibrillation Is Too Much: Contemporary and Future Ma…

Stanford Medicine

A. Perino

"Pill-in-Pocket" - Anticoagulation for AF

Northwestern Medicine Cardiovascular Care

R. Passman

Atrial Fibrillation as the "Non-Ablationist" - A Continuum in Risk …

The American Society for Preventive Cardiology

L. Wang

AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atr…

AHA 2023 Insights

J. Healey

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Georgia Heart Institute

D. Weisman, C. Ellis

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Complex Coronary Cases

U. Baber

Stroke Prevention in Atrial Fibrillation

Penn Medicine Heart and Vascular Center

D. Goldberg

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

ACC 2023 Conference Coverage

A. Natale

Peri-Operative Management of Anticoagulation

Icahn School of Medicine at Mount Sinai

A. Dunn

Rationale and Practical Aspects for using NOAC’s to Treat Afib and V…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

D. Blanchard

Insights into Advances in Nonvalvular Atrial Fibrillation: Exploring…

The France Foundation

C. Ruff, J. Walker